The immunology underlying CNS autoantibody diseases
The past two decades have seen a considerable paradigm shift in the way autoimmune CNS disorders are considered, diagnosed, and treated; largely due to the discovery of novel autoantibodies directed at neuroglial surface or intracellular targets. This approach has enabled multiple bona fide CNS auto...
Main Authors: | Cleaver, J, Ceronie, B, Strippel, C, Handel, A, Irani, SR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2024
|
Similar Items
-
Autoimmune encephalitis: recent clinical and biological advances
by: Varley, JA, et al.
Published: (2023) -
Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease
by: Ceronie, B, et al.
Published: (2025) -
Immunotherapy-responsive neuropathic pain and allodynia in a patient with glycine receptor autoantibodies: a case report
by: Soleimani, B, et al.
Published: (2023) -
Neutralizing autoantibodies against interleukin-10 in inflammatory bowel disease
by: Griffin, H, et al.
Published: (2024) -
IMMUNOLOGY /
by: Roitt, Ivan, Emiritus Professor, author 172168, et al.
Published: (1998)